Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Tags:
Lpath, Pfizer, iSONEP, Asonept, macular degeneration, multiple sclerosis, MS, Regeneron, Roche, Bayer, Sanofi, Valeant Pharmaceuticals, GSK
Regeneron posts strong 3rd-quarter results on new approvals; raises Eylea sales estimate
Yahoo/AP
Wed, 10/24/12 - 11:55 am
Tags:
earnings, Regeneron
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Mon, 10/22/12 - 10:52 am
Tags:
Regeneron, Eyela, Gilead, GS-7977, Merck, Eli Lilly, Singulair, Molina Healthcare
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Mon, 10/1/12 - 09:52 pm
Tags:
M&A, AstraZeneca, Seattle Genetics, Regeneron, ONYX Pharmaceuticals, Biomarin, Forest Labs
2 Drug Approvals and Shares Drop? That's Biotech!
Motley Fool
Tue, 09/25/12 - 09:46 am
Tags:
Regeneron, Eylea, macular edema, age-related macular degeneration
Regeneron Eylea likely to be approved for CRVO, says RBC Capital
Yahoo/Fly on the Wall
Mon, 09/17/12 - 10:51 am
Tags:
Regeneron, Eylea, central retinal vein occlusion
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Health Care Winner
The Street
Sat, 09/15/12 - 09:27 am
Tags:
Regeneron
Gilead, Salix, Peregrine, Navidea Approach Key Dates In September
Minyanville
Tue, 09/4/12 - 12:27 pm
Tags:
Gilead, Salix, Peregrine Pharmaceuticals, Navidea Biopharmaceuticals, Crofelemer, tobramycin, Lymphoseek, bavituximab, Truvada, Eylea, Regeneron, lixivaptan, Cornerstone Therapeutics
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wed, 08/29/12 - 12:21 pm
Tags:
Big Pharma, Lipitor, Anacetrapib, Merck, Plavix, Pfizer, Bristol-Myers Squibb, PCSK9 inhibitor, Sanofi, Regeneron, darapladib, Roche, GSK
Can Anything Stop Regeneron Pharmaceuticals?
Motley Fool
Mon, 08/27/12 - 12:29 pm
Tags:
Regeneron
Healthcare Business Review: Impax’s Promising Future, Regeneron’s Relationship With Sanofi
Wall St. Cheat Sheet
Fri, 08/24/12 - 11:10 am
Tags:
Impax, Sanofi, Regeneron, Wright Medical
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Seeking Alpha
Sat, 08/18/12 - 03:34 pm
Tags:
Amgen, Celgene, Alexion, Regeneron
3 Drugs Approved, but Only 1 Matters
Motley Fool
Tue, 08/7/12 - 11:43 am
Tags:
FDA, drug approvals, Regeneron, Arcalyst, Eyelea, Novartis, Sanofi, Zaltrap
Why Regeneron May Not Profit Much From Today's FDA Approval
Forbes
Sat, 08/4/12 - 12:07 pm
Tags:
Regeneron, Zaltrap, colorectal cancer
FDA approves Sanofi/Regeneron colon cancer drug
Reuters
Fri, 08/3/12 - 02:24 pm
Tags:
FDA, Sanofi, Regeneron, colon cancer, Zaltrap
6 Healthcare Stocks With Pending August Catalysts
Seeking Alpha
Wed, 08/1/12 - 10:08 am
Tags:
Abbott Labs, Amgen, Amarin, Arena Pharmaceuticals, Gilead, JNJ, Pfizer, Horizon Pharma, Vivus, Regeneron, Sanofi, Talon Therapeutics
Gilead, Regeneron, Sanofi, Pfizer, Abbott Face Big Dates in August
Minyanville
Tue, 07/31/12 - 01:27 pm
Tags:
Gilead, Regeneron, Sanofi, Pfizer, Abbott Labs
FDA rejects expanded use of Regeneron drug for gout
Reuters
Tue, 07/31/12 - 11:06 am
Tags:
Regeneron, gout, FDA, Arcalyst
Biotechs In Motion As New Drug Pipeline Brims
investors.com
Sun, 07/29/12 - 01:00 pm
Tags:
Amgen, Celgene, Biogen Idec, Gilead Sciences, Regeneron, Vertex Pharmaceuticals, Alexion, Arena Pharmaceuticals, ONYX Pharmaceuticals, United Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.